Olink Holding AB (OLK)
22.99
+0.32
(+1.41%)
USD |
NASDAQ |
May 02, 16:00
22.99
0.00 (0.00%)
After-Hours: 20:00
Olink Shareholders Equity (Quarterly): 502.70M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 502.70M |
| September 30, 2023 | 472.10M |
| June 30, 2023 | 470.50M |
| March 31, 2023 | 497.98M |
| December 31, 2022 | 410.68M |
| September 30, 2022 | 378.90M |
| June 30, 2022 | 410.75M |
| Date | Value |
|---|---|
| March 31, 2022 | 454.55M |
| December 31, 2021 | 475.68M |
| September 30, 2021 | 495.16M |
| June 30, 2021 | 516.70M |
| March 31, 2021 | 510.27M |
| December 31, 2020 | 299.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
299.70M
Minimum
Dec 2020
516.70M
Maximum
Jun 2021
453.51M
Average
472.10M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Thermo Fisher Scientific Inc | 45.50B |
| Abliva AB | 7.025M |
| Karolinska Development AB | 117.06M |
| Calliditas Therapeutics AB | 33.26M |
| Oncopeptides AB | 12.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 602.25M |
| Total Liabilities (Quarterly) | 99.55M |
| Current Ratio | 4.748 |